OTCMKTS:PVOTF BetterLife Pharma (PVOTF) Stock Price, News & Analysis → A new way to collect income from stocks (From DTI) (Ad) Free PVOTF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.13▼$0.1352-Week Range N/AVolume198,200 shsAverage Volume52,703 shsMarket Capitalization$21.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BetterLife Pharma alerts: Email Address Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << About BetterLife Pharma Stock (OTCMKTS:PVOTF)BetterLife Pharma, Inc. is an early stage pharmaceutical company, which engages in the development and commercialization of therapeutic pharmaceutical and nutraceutical products. It also offers drug delivery platform technologies. Its product lines include capsules, tablets, and softgels; bulk powder; stick packs; beverages; oral solutions; lotions, creams, and gels; pet food additives; gum, mints, and candies; and sexual health products. It distributes its product under the Pivot Naturals brand. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.Read More Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << PVOTF Stock News HeadlinesApril 26, 2024 | msn.com$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management DrugsApril 17, 2024 | msn.comJardiance and Ofev propel Boehringer’s human pharma salesApril 28, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.April 15, 2024 | abcnews.go.comVertex Pharma scientist talks about the long road to developing non-addictive painkillersApril 11, 2024 | tmcnet.comBetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 4, 2024 | msn.comVictory Over Big Pharma Will Take More Than the IRAMarch 4, 2024 | finanznachrichten.deBetterLife Pharma Inc.: BetterLife's 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityFebruary 5, 2024 | theguardian.comThe tragedy of Leonard Farruku, the gifted young musician whose dream of a better life ended on the Bibby StockholmApril 28, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…February 1, 2024 | msn.comWeight loss drugs could create the first $1 trillion pharma companiesJanuary 2, 2024 | finance.yahoo.comBetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001November 16, 2023 | msn.comBig Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity ratesNovember 15, 2023 | tmcnet.comUS Patent and Trademark Office Publishes BetterLife's Comprehensive Patent for BETR-001 and Other LSD DerivativesNovember 13, 2023 | businesswire.comMedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749)October 25, 2023 | finance.yahoo.comLi3 Lithium Announces Appointment of Robert Metcalfe to the Board of DirectorsJune 28, 2023 | msn.comBetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD DerivativesMarch 12, 2023 | finance.yahoo.comEsperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQJanuary 26, 2023 | benzinga.comBetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial ProgramsJanuary 22, 2023 | ca.finance.yahoo.comBetterLife Pharma Inc. (BETR.CN)June 21, 2022 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) ForumSee More Headlines Receive PVOTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:PVOTF Previous SymbolOTCMKTS:PVOTF CUSIPN/A CIK1464165 Webpivotpharma.com Phone(604) 805-7783FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,780,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-205.15% Return on Assets-147.23% Debt Debt-to-Equity RatioN/A Current Ratio3.62 Quick Ratio3.62 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares171,414,000Free FloatN/AMarket Cap$21.70 million OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesAhmad DoroudianChief Executive Officer & DirectorChris LuckyChief Operating OfficerMoira OngChief Financial OfficerKey CompetitorsMEI PharmaNASDAQ:MEIPSynlogicNASDAQ:SYBXGreen Organic DutchmanOTCMKTS:TGODFGlucoTrackNASDAQ:GCTKTherapeuticsMDNASDAQ:TXMDView All Competitors PVOTF Stock Analysis - Frequently Asked Questions How do I buy shares of BetterLife Pharma? Shares of PVOTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PVOTF) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.